Global Mesalamine Market Growth 2022-2028
As the global economy mends, the 2021 growth of Mesalamine will have significant change from previous year. According to our latest study, the global Mesalamine market size is USD million in 2022 from USD 153.1 million in 2021, with a change of % between 2021 and 2022. The global Mesalamine market size will reach USD 192.4 million in 2028, growing at a CAGR of 3.3% over the analysis period.
The United States Mesalamine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Mesalamine market, reaching US$ million by the year 2028. As for the Europe Mesalamine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Mesalamine players cover Syntese A/S, Divis Laboratories, Cambrex Corporation, and Ipca Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalamine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Mesalazine Tablets
Mesalazine Capsules
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
Hangzhou Brother
PharmaZell
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mesalamine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Mesalamine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Mesalamine by Country/Region, 2017, 2022 & 2028
2.2 Mesalamine Segment by Type
2.2.1 Purity ≥ 97%
2.2.2 Purity ≥ 98%
2.2.3 Purity ≥ 99%
2.3 Mesalamine Sales by Type
2.3.1 Global Mesalamine Sales Market Share by Type (2017-2022)
2.3.2 Global Mesalamine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Mesalamine Sale Price by Type (2017-2022)
2.4 Mesalamine Segment by Application
2.4.1 Mesalazine Tablets
2.4.2 Mesalazine Capsules
2.4.3 Others
2.5 Mesalamine Sales by Application
2.5.1 Global Mesalamine Sale Market Share by Application (2017-2022)
2.5.2 Global Mesalamine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Mesalamine Sale Price by Application (2017-2022)
3 Global Mesalamine by Company
3.1 Global Mesalamine Breakdown Data by Company
3.1.1 Global Mesalamine Annual Sales by Company (2020-2022)
3.1.2 Global Mesalamine Sales Market Share by Company (2020-2022)
3.2 Global Mesalamine Annual Revenue by Company (2020-2022)
3.2.1 Global Mesalamine Revenue by Company (2020-2022)
3.2.2 Global Mesalamine Revenue Market Share by Company (2020-2022)
3.3 Global Mesalamine Sale Price by Company
3.4 Key Manufacturers Mesalamine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalamine Product Location Distribution
3.4.2 Players Mesalamine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Mesalamine by Geographic Region
4.1 World Historic Mesalamine Market Size by Geographic Region (2017-2022)
4.1.1 Global Mesalamine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Mesalamine Annual Revenue by Geographic Region
4.2 World Historic Mesalamine Market Size by Country/Region (2017-2022)
4.2.1 Global Mesalamine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Mesalamine Annual Revenue by Country/Region
4.3 Americas Mesalamine Sales Growth
4.4 APAC Mesalamine Sales Growth
4.5 Europe Mesalamine Sales Growth
4.6 Middle East & Africa Mesalamine Sales Growth
5 Americas
5.1 Americas Mesalamine Sales by Country
5.1.1 Americas Mesalamine Sales by Country (2017-2022)
5.1.2 Americas Mesalamine Revenue by Country (2017-2022)
5.2 Americas Mesalamine Sales by Type
5.3 Americas Mesalamine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalamine Sales by Region
6.1.1 APAC Mesalamine Sales by Region (2017-2022)
6.1.2 APAC Mesalamine Revenue by Region (2017-2022)
6.2 APAC Mesalamine Sales by Type
6.3 APAC Mesalamine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Mesalamine by Country
7.1.1 Europe Mesalamine Sales by Country (2017-2022)
7.1.2 Europe Mesalamine Revenue by Country (2017-2022)
7.2 Europe Mesalamine Sales by Type
7.3 Europe Mesalamine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mesalamine by Country
8.1.1 Middle East & Africa Mesalamine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Mesalamine Revenue by Country (2017-2022)
8.2 Middle East & Africa Mesalamine Sales by Type
8.3 Middle East & Africa Mesalamine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesalamine
10.3 Manufacturing Process Analysis of Mesalamine
10.4 Industry Chain Structure of Mesalamine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesalamine Distributors
11.3 Mesalamine Customer
12 World Forecast Review for Mesalamine by Geographic Region
12.1 Global Mesalamine Market Size Forecast by Region
12.1.1 Global Mesalamine Forecast by Region (2023-2028)
12.1.2 Global Mesalamine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mesalamine Forecast by Type
12.7 Global Mesalamine Forecast by Application
13 Key Players Analysis
13.1 Syntese A/S
13.1.1 Syntese A/S Company Information
13.1.2 Syntese A/S Mesalamine Product Offered
13.1.3 Syntese A/S Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Syntese A/S Main Business Overview
13.1.5 Syntese A/S Latest Developments
13.2 Divis Laboratories
13.2.1 Divis Laboratories Company Information
13.2.2 Divis Laboratories Mesalamine Product Offered
13.2.3 Divis Laboratories Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Divis Laboratories Main Business Overview
13.2.5 Divis Laboratories Latest Developments
13.3 Cambrex Corporation
13.3.1 Cambrex Corporation Company Information
13.3.2 Cambrex Corporation Mesalamine Product Offered
13.3.3 Cambrex Corporation Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Cambrex Corporation Main Business Overview
13.3.5 Cambrex Corporation Latest Developments
13.4 Ipca Laboratories
13.4.1 Ipca Laboratories Company Information
13.4.2 Ipca Laboratories Mesalamine Product Offered
13.4.3 Ipca Laboratories Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ipca Laboratories Main Business Overview
13.4.5 Ipca Laboratories Latest Developments
13.5 Hangzhou Brother
13.5.1 Hangzhou Brother Company Information
13.5.2 Hangzhou Brother Mesalamine Product Offered
13.5.3 Hangzhou Brother Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hangzhou Brother Main Business Overview
13.5.5 Hangzhou Brother Latest Developments
13.6 PharmaZell
13.6.1 PharmaZell Company Information
13.6.2 PharmaZell Mesalamine Product Offered
13.6.3 PharmaZell Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 PharmaZell Main Business Overview
13.6.5 PharmaZell Latest Developments
13.7 Lianyungang Fengheng Biopharm
13.7.1 Lianyungang Fengheng Biopharm Company Information
13.7.2 Lianyungang Fengheng Biopharm Mesalamine Product Offered
13.7.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Lianyungang Fengheng Biopharm Main Business Overview
13.7.5 Lianyungang Fengheng Biopharm Latest Developments
13.8 Lasa Loboratory
13.8.1 Lasa Loboratory Company Information
13.8.2 Lasa Loboratory Mesalamine Product Offered
13.8.3 Lasa Loboratory Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Lasa Loboratory Main Business Overview
13.8.5 Lasa Loboratory Latest Developments
13.9 Erregierre SpA
13.9.1 Erregierre SpA Company Information
13.9.2 Erregierre SpA Mesalamine Product Offered
13.9.3 Erregierre SpA Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Erregierre SpA Main Business Overview
13.9.5 Erregierre SpA Latest Developments
13.10 Corden Pharma Bergamo
13.10.1 Corden Pharma Bergamo Company Information
13.10.2 Corden Pharma Bergamo Mesalamine Product Offered
13.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Corden Pharma Bergamo Main Business Overview
13.10.5 Corden Pharma Bergamo Latest Developments
13.11 CTX Lifescience
13.11.1 CTX Lifescience Company Information
13.11.2 CTX Lifescience Mesalamine Product Offered
13.11.3 CTX Lifescience Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 CTX Lifescience Main Business Overview
13.11.5 CTX Lifescience Latest Developments
13.12 Ishita Active Pharma Ingredients
13.12.1 Ishita Active Pharma Ingredients Company Information
13.12.2 Ishita Active Pharma Ingredients Mesalamine Product Offered
13.12.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Ishita Active Pharma Ingredients Main Business Overview
13.12.5 Ishita Active Pharma Ingredients Latest Developments
13.13 YC Biotech (Jiangsu)
13.13.1 YC Biotech (Jiangsu) Company Information
13.13.2 YC Biotech (Jiangsu) Mesalamine Product Offered
13.13.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 YC Biotech (Jiangsu) Main Business Overview
13.13.5 YC Biotech (Jiangsu) Latest Developments
13.14 Xinxiang Tianfeng Fine Chemical
13.14.1 Xinxiang Tianfeng Fine Chemical Company Information
13.14.2 Xinxiang Tianfeng Fine Chemical Mesalamine Product Offered
13.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Xinxiang Tianfeng Fine Chemical Main Business Overview
13.14.5 Xinxiang Tianfeng Fine Chemical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Mesalamine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Mesalamine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Purity ≥ 97%
Table 4. Major Players of Purity ≥ 98%
Table 5. Major Players of Purity ≥ 99%
Table 6. Global Mesalamine Sales by Type (2017-2022) & (MT)
Table 7. Global Mesalamine Sales Market Share by Type (2017-2022)
Table 8. Global Mesalamine Revenue by Type (2017-2022) & ($ million)
Table 9. Global Mesalamine Revenue Market Share by Type (2017-2022)
Table 10. Global Mesalamine Sale Price by Type (2017-2022) & (USD/Kg)
Table 11. Global Mesalamine Sales by Application (2017-2022) & (MT)
Table 12. Global Mesalamine Sales Market Share by Application (2017-2022)
Table 13. Global Mesalamine Revenue by Application (2017-2022)
Table 14. Global Mesalamine Revenue Market Share by Application (2017-2022)
Table 15. Global Mesalamine Sale Price by Application (2017-2022) & (USD/Kg)
Table 16. Global Mesalamine Sales by Company (2020-2022) & (MT)
Table 17. Global Mesalamine Sales Market Share by Company (2020-2022)
Table 18. Global Mesalamine Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Mesalamine Revenue Market Share by Company (2020-2022)
Table 20. Global Mesalamine Sale Price by Company (2020-2022) & (USD/Kg)
Table 21. Key Manufacturers Mesalamine Producing Area Distribution and Sales Area
Table 22. Players Mesalamine Products Offered
Table 23. Mesalamine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Mesalamine Sales by Geographic Region (2017-2022) & (MT)
Table 27. Global Mesalamine Sales Market Share Geographic Region (2017-2022)
Table 28. Global Mesalamine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Mesalamine Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Mesalamine Sales by Country/Region (2017-2022) & (MT)
Table 31. Global Mesalamine Sales Market Share by Country/Region (2017-2022)
Table 32. Global Mesalamine Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Mesalamine Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Mesalamine Sales by Country (2017-2022) & (MT)
Table 35. Americas Mesalamine Sales Market Share by Country (2017-2022)
Table 36. Americas Mesalamine Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Mesalamine Revenue Market Share by Country (2017-2022)
Table 38. Americas Mesalamine Sales by Type (2017-2022) & (MT)
Table 39. Americas Mesalamine Sales Market Share by Type (2017-2022)
Table 40. Americas Mesalamine Sales by Application (2017-2022) & (MT)
Table 41. Americas Mesalamine Sales Market Share by Application (2017-2022)
Table 42. APAC Mesalamine Sales by Region (2017-2022) & (MT)
Table 43. APAC Mesalamine Sales Market Share by Region (2017-2022)
Table 44. APAC Mesalamine Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Mesalamine Revenue Market Share by Region (2017-2022)
Table 46. APAC Mesalamine Sales by Type (2017-2022) & (MT)
Table 47. APAC Mesalamine Sales Market Share by Type (2017-2022)
Table 48. APAC Mesalamine Sales by Application (2017-2022) & (MT)
Table 49. APAC Mesalamine Sales Market Share by Application (2017-2022)
Table 50. Europe Mesalamine Sales by Country (2017-2022) & (MT)
Table 51. Europe Mesalamine Sales Market Share by Country (2017-2022)
Table 52. Europe Mesalamine Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Mesalamine Revenue Market Share by Country (2017-2022)
Table 54. Europe Mesalamine Sales by Type (2017-2022) & (MT)
Table 55. Europe Mesalamine Sales Market Share by Type (2017-2022)
Table 56. Europe Mesalamine Sales by Application (2017-2022) & (MT)
Table 57. Europe Mesalamine Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Mesalamine Sales by Country (2017-2022) & (MT)
Table 59. Middle East & Africa Mesalamine Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Mesalamine Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Mesalamine Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Mesalamine Sales by Type (2017-2022) & (MT)
Table 63. Middle East & Africa Mesalamine Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Mesalamine Sales by Application (2017-2022) & (MT)
Table 65. Middle East & Africa Mesalamine Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Mesalamine
Table 67. Key Market Challenges & Risks of Mesalamine
Table 68. Key Industry Trends of Mesalamine
Table 69. Mesalamine Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Mesalamine Distributors List
Table 72. Mesalamine Customer List
Table 73. Global Mesalamine Sales Forecast by Region (2023-2028) & (MT)
Table 74. Global Mesalamine Sales Market Forecast by Region
Table 75. Global Mesalamine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Mesalamine Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Mesalamine Sales Forecast by Country (2023-2028) & (MT)
Table 78. Americas Mesalamine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Mesalamine Sales Forecast by Region (2023-2028) & (MT)
Table 80. APAC Mesalamine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Mesalamine Sales Forecast by Country (2023-2028) & (MT)
Table 82. Europe Mesalamine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Mesalamine Sales Forecast by Country (2023-2028) & (MT)
Table 84. Middle East & Africa Mesalamine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Mesalamine Sales Forecast by Type (2023-2028) & (MT)
Table 86. Global Mesalamine Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Mesalamine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Mesalamine Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Mesalamine Sales Forecast by Application (2023-2028) & (MT)
Table 90. Global Mesalamine Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Mesalamine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Mesalamine Revenue Market Share Forecast by Application (2023-2028)
Table 93. Syntese A/S Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 94. Syntese A/S Mesalamine Product Offered
Table 95. Syntese A/S Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 96. Syntese A/S Main Business
Table 97. Syntese A/S Latest Developments
Table 98. Divis Laboratories Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 99. Divis Laboratories Mesalamine Product Offered
Table 100. Divis Laboratories Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 101. Divis Laboratories Main Business
Table 102. Divis Laboratories Latest Developments
Table 103. Cambrex Corporation Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 104. Cambrex Corporation Mesalamine Product Offered
Table 105. Cambrex Corporation Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 106. Cambrex Corporation Main Business
Table 107. Cambrex Corporation Latest Developments
Table 108. Ipca Laboratories Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 109. Ipca Laboratories Mesalamine Product Offered
Table 110. Ipca Laboratories Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 111. Ipca Laboratories Main Business
Table 112. Ipca Laboratories Latest Developments
Table 113. Hangzhou Brother Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 114. Hangzhou Brother Mesalamine Product Offered
Table 115. Hangzhou Brother Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 116. Hangzhou Brother Main Business
Table 117. Hangzhou Brother Latest Developments
Table 118. PharmaZell Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 119. PharmaZell Mesalamine Product Offered
Table 120. PharmaZell Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 121. PharmaZell Main Business
Table 122. PharmaZell Latest Developments
Table 123. Lianyungang Fengheng Biopharm Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 124. Lianyungang Fengheng Biopharm Mesalamine Product Offered
Table 125. Lianyungang Fengheng Biopharm Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 126. Lianyungang Fengheng Biopharm Main Business
Table 127. Lianyungang Fengheng Biopharm Latest Developments
Table 128. Lasa Loboratory Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 129. Lasa Loboratory Mesalamine Product Offered
Table 130. Lasa Loboratory Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 131. Lasa Loboratory Main Business
Table 132. Lasa Loboratory Latest Developments
Table 133. Erregierre SpA Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 134. Erregierre SpA Mesalamine Product Offered
Table 135. Erregierre SpA Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 136. Erregierre SpA Main Business
Table 137. Erregierre SpA Latest Developments
Table 138. Corden Pharma Bergamo Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 139. Corden Pharma Bergamo Mesalamine Product Offered
Table 140. Corden Pharma Bergamo Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 141. Corden Pharma Bergamo Main Business
Table 142. Corden Pharma Bergamo Latest Developments
Table 143. CTX Lifescience Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 144. CTX Lifescience Mesalamine Product Offered
Table 145. CTX Lifescience Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 146. CTX Lifescience Main Business
Table 147. CTX Lifescience Latest Developments
Table 148. Ishita Active Pharma Ingredients Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 149. Ishita Active Pharma Ingredients Mesalamine Product Offered
Table 150. Ishita Active Pharma Ingredients Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 151. Ishita Active Pharma Ingredients Main Business
Table 152. Ishita Active Pharma Ingredients Latest Developments
Table 153. YC Biotech (Jiangsu) Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 154. YC Biotech (Jiangsu) Mesalamine Product Offered
Table 155. YC Biotech (Jiangsu) Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 156. YC Biotech (Jiangsu) Main Business
Table 157. YC Biotech (Jiangsu) Latest Developments
Table 158. Xinxiang Tianfeng Fine Chemical Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 159. Xinxiang Tianfeng Fine Chemical Mesalamine Product Offered
Table 160. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 161. Xinxiang Tianfeng Fine Chemical Main Business
Table 162. Xinxiang Tianfeng Fine Chemical Latest Developments
List of Figures
Figure 1. Picture of Mesalamine
Figure 2. Mesalamine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesalamine Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Mesalamine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Mesalamine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Purity ≥ 97%
Figure 10. Product Picture of Purity ≥ 98%
Figure 11. Product Picture of Purity ≥ 99%
Figure 12. Global Mesalamine Sales Market Share by Type in 2021
Figure 13. Global Mesalamine Revenue Market Share by Type (2017-2022)
Figure 14. Mesalamine Consumed in Mesalazine Tablets
Figure 15. Global Mesalamine Market: Mesalazine Tablets (2017-2022) & (MT)
Figure 16. Mesalamine Consumed in Mesalazine Capsules
Figure 17. Global Mesalamine Market: Mesalazine Capsules (2017-2022) & (MT)
Figure 18. Mesalamine Consumed in Others
Figure 19. Global Mesalamine Market: Others (2017-2022) & (MT)
Figure 20. Global Mesalamine Sales Market Share by Application (2017-2022)
Figure 21. Global Mesalamine Revenue Market Share by Application in 2021
Figure 22. Mesalamine Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Mesalamine Revenue Market Share by Company in 2021
Figure 24. Global Mesalamine Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Mesalamine Revenue Market Share by Geographic Region in 2021
Figure 26. Global Mesalamine Sales Market Share by Region (2017-2022)
Figure 27. Global Mesalamine Revenue Market Share by Country/Region in 2021
Figure 28. Americas Mesalamine Sales 2017-2022 (MT)
Figure 29. Americas Mesalamine Revenue 2017-2022 ($ Millions)
Figure 30. APAC Mesalamine Sales 2017-2022 (MT)
Figure 31. APAC Mesalamine Revenue 2017-2022 ($ Millions)
Figure 32. Europe Mesalamine Sales 2017-2022 (MT)
Figure 33. Europe Mesalamine Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Mesalamine Sales 2017-2022 (MT)
Figure 35. Middle East & Africa Mesalamine Revenue 2017-2022 ($ Millions)
Figure 36. Americas Mesalamine Sales Market Share by Country in 2021
Figure 37. Americas Mesalamine Revenue Market Share by Country in 2021
Figure 38. United States Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Mesalamine Sales Market Share by Region in 2021
Figure 43. APAC Mesalamine Revenue Market Share by Regions in 2021
Figure 44. China Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Mesalamine Sales Market Share by Country in 2021
Figure 51. Europe Mesalamine Revenue Market Share by Country in 2021
Figure 52. Germany Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Mesalamine Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Mesalamine Revenue Market Share by Country in 2021
Figure 59. Egypt Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Mesalamine Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Mesalamine in 2021
Figure 65. Manufacturing Process Analysis of Mesalamine
Figure 66. Industry Chain Structure of Mesalamine
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
